Form 8-K - Current report:
SEC Accession No. 0001193125-19-299994
Filing Date
2019-11-25
Accepted
2019-11-25 17:01:05
Documents
16
Period of Report
2019-11-25
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d839912d8k.htm   iXBRL 8-K 46299
2 EX-4.2 d839912dex42.htm EX-4.2 329051
3 EX-4.4 d839912dex44.htm EX-4.4 113442
4 EX-4.6 d839912dex46.htm EX-4.6 315914
5 EX-4.8 d839912dex48.htm EX-4.8 115779
  Complete submission text file 0001193125-19-299994.txt   1245651

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA teva-20191125.xsd EX-101.SCH 3074
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE teva-20191125_lab.xml EX-101.LAB 18072
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE teva-20191125_pre.xml EX-101.PRE 11387
16 EXTRACTED XBRL INSTANCE DOCUMENT d839912d8k_htm.xml XML 3429
Mailing Address TEVA PHARMACEUTICAL INDUSTRIES LIMITED 5 BAZEL ST PO B 3190 PETACH TIKVA L3 49131
Business Address 5 BAZEL ST P O B 3190 PETACH TIKVA L3 49131 9729267267
TEVA PHARMACEUTICAL INDUSTRIES LTD (Filer) CIK: 0000818686 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-16174 | Film No.: 191246862
SIC: 2834 Pharmaceutical Preparations